Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.38 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.38 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.38 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.35 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL935232 | 0.93 | THRB (0.41) | LMNAEGLN1ALKBH5SUCNR1THRB | |
| SCHEMBL5483523 | 0.91 | THRB (0.44) | LMNAEGLN1ALKBH5SUCNR1THRB | |
| SCHEMBL5490761 | 0.91 | THRB (0.44) | LMNAEGLN1ALKBH5SUCNR1THRB | |
| SCHEMBL934065 | 0.91 | THRB (0.44) | LMNAEGLN1ALKBH5SUCNR1THRB | |
| SCHEMBL1827086 | 0.91 | THRB (0.44) | LMNAEGLN1ALKBH5SUCNR1THRB | |
| SCHEMBL5488963 | 0.91 | THRB (0.44) | LMNAEGLN1ALKBH5SUCNR1THRB | |
| SCHEMBL5490493 | 0.91 | THRB (0.44) | LMNAEGLN1ALKBH5SUCNR1THRB | |
| SCHEMBL5485779 | 0.91 | THRB (0.44) | LMNAEGLN1ALKBH5SUCNR1THRB | |
| SCHEMBL1828702 | 0.91 | THRB (0.44) | LMNAEGLN1ALKBH5SUCNR1THRB | |
| SCHEMBL1519575 | 0.91 | THRB (0.44) | LMNAEGLN1ALKBH5SUCNR1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4527829-A1 | PROCESS FOR THE PURIFICATION OF PERFLUOROALKYL ACIDS | Chiron AS (NO) | 2025-03-26 | — | — | EP | claimed |
| WO-2023107629-A1 | MATERIALS FOR THE CAPTURE OF SUBSTANCES | Membrion, Inc. (US) | 2023-06-15 | — | — | WO | claimed |
| CN-110770271-B | Method for preparing functionalized fluorinated monomers, fluorinated monomers and compositions for preparing same | 埃特纳科技有限公司 | 2023-04-18 | — | — | CN | claimed |
| EP-3635022-A1 | METHODS FOR MAKING FUNCTIONALIZED FLUORINATED MONOMERS, FLUORINATED MONOMERS, AND COMPOSITIONS FOR MAKING THE SAME | Etna-Tec, Ltd (US) | 2020-04-15 | — | — | EP | claimed |
| CN-110770271-A | Method for preparing functionalized fluorinated monomers, fluorinated monomers and compositions for preparing same | 埃特纳科技有限公司 | 2020-02-07 | — | — | CN | claimed |
| WO-2018213850-A1 | METHODS FOR MAKING FUNCTIONALIZED FLUORINATED MONOMERS, FLUORINATED MONOMERS, AND COMPOSITIONS FOR MAKING THE SAME | ETNA-TEC, LTD (US) | 2018-11-22 | — | — | WO | claimed |
| US-20180334416-A1 | Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same | ETNA-TEC, LTD. | 2018-11-22 | — | — | US | claimed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| US-12576297-B2 | Apparatus and methods for sonochemical degradation of per- and polyfluoroalkyl substances | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-03-17 | — | — | US | disclosed |
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-03-17 | — | — | US | disclosed |
| EP-4686757-A1 | INHIBITORS OF EXPRESSION AND/OR FUNCTION | e-therapeutics PLC (GB) | 2026-02-04 | — | — | EP | disclosed |
| US-12392782-B2 | Characterization of protein binding to per- and polyfluoroalkyl substances | NORTH CAROLINA STATE UNIVERSITY (US) | 2025-08-19 | — | — | US | disclosed |
| EP-3635022-B1 | METHODS FOR MAKING FUNCTIONALIZED FLUORINATED MONOMERS, FLUORINATED MONOMERS, AND COMPOSITIONS FOR MAKING THE SAME | ETNA TEC LTD (US) | 2025-05-21 | — | — | EP | disclosed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | disclosed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | disclosed |
| US-6264929-B1 | COMPLEX | WELLA AKTIENGESELLSCHAFT (DE) | 2001-07-24 | — | — | US | disclosed |
| EP-0943312-A2 | Hair- care products with fluorinated acids and polymers | Wella Aktiengesellschaft (DE) | 1999-09-22 | — | — | EP | disclosed |
| EP-0837085-A1 | POLYCARBONATE-BASE POLYMER, PRODUCTION PROCESS, RESIN COATING FLUID PREPARED THEREFROM, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR PREPARED THEREFROM | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1998-04-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | CD38, PARP9, MCCC2 | LMNA 1936/4885EGLN1 271/4885ALKBH5 68/4885 |
| US-12576297-B2 | Apparatus and methods for sonochemical degradation of per- and polyfluoroalkyl substances | PFAS, PIEZO1, UFL1 | LMNA 1329/4885EGLN1 993/4885ALKBH5 2079/4885 |
| US-20180334416-A1 | Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same | ALKBH3, FTO, ALK | LMNA 1234/4885EGLN1 201/4885ALKBH5 25/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.